Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Pushes For Prescription-Only Sale Of Skin-Bleaching Products

This article was originally published in The Tan Sheet

Executive Summary

FDA is proposing a rule that classifies all over-the-counter skin-bleaching products as drugs requiring an approved new drug application, the agency announced in a notice of proposed rulemaking published in an Aug. 29 Federal Register notice

You may also be interested in...



Proposed Hydroquinone Ban Criticized In Literature Review

Disrupting the availability of hydroquinone skin-lightening products would represent an "overreaction" by FDA, according to a literature review published in the November issue of the Journal of the American Academy of Dermatology

Proposed Hydroquinone Ban Criticized In Literature Review

Disrupting the availability of hydroquinone skin-lightening products would represent an "overreaction" by FDA, according to a literature review published in the November issue of the Journal of the American Academy of Dermatology

FDA Hydroquinone Proposal Should Prompt Industry Studies – Dermatologists

Dermatologists concerned about losing over-the-counter access to skin bleaching products formulated with hydroquinone - as proposed by FDA - are counting on industry to submit compelling safety data

Related Content

Topics

UsernamePublicRestriction

Register

PS099719

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel